| Literature DB >> 31200525 |
Idam Hermawan1, Mikako Higa2, Philipus Uli Basa Hutabarat3, Takeshi Fujiwara4, Kiyotaka Akiyama5, Akihiko Kanamoto6, Takahiro Haruyama7, Nobuyuki Kobayashi8, Masahiro Higashi9, Shoichiro Suda10, Junichi Tanaka11.
Abstract
On our quest for new bioactive molecules from marine sources, two cyclic imines (1, 2) were isolated from a dinoflagellate extract, inhibiting the growth of the respiratory syncytial virus (RSV). Compound 1 was identified as a known molecule portimine, while 2 was elucidated to be a new cyclic imine, named kabirimine. The absolute stereochemistry of 1 was determined by crystallographic work and chiral derivatization, whereas the structure of 2 was elucidated by means of spectroscopic analysis and computational study on all the possible isomers. Compound 1 showed potent cytotoxicity (CC50 < 0.097 µM) against HEp2 cells, while 2 exhibited moderate antiviral activity against RSV with IC50 = 4.20 µM (95% CI 3.31-5.33).Entities:
Keywords: cyclic imine; dinoflagellate; kabirimine; portimine; respiratory syncytial virus (RSV)
Mesh:
Substances:
Year: 2019 PMID: 31200525 PMCID: PMC6627061 DOI: 10.3390/md17060353
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of portimine (1) and kabirimine (2).
Figure 2Oak Ridge Thermal-Ellipsoid Plot (ORTEP) diagram of portimine (1).
1H and 13C NMR data for kabirimine (2) in dimethyl sulfoxide (DMSO)-d6.
| Position | δC | δH ( | COSY | HMBC |
|---|---|---|---|---|
| 1 | 42.1, CH2 | 3.77 brs (2H) | 2 | |
| 2 | 24.7, CH2 | 2.14 m; 1.62 m | 1; - | |
| 3 | 25.3, CH | 2.08 m | 27 | |
| 4 | 48.1, C | - | ||
| 5 | 172.5, C | - | ||
| 6 | 29.0, CH2 | 3.13 brd (11.2); 2.92 m | 7; - | |
| 7 | 27.3, CH2 | 2.34 brt (11.2); 1.65 m | 6; 8 | |
| 8 | 72.5, CH | 3.93 m | ||
| 9 | 31.2, CH2 | 2.00 m; 1.43 brt (9.6) | 8, 10; 8 | |
| 10 | 39.0, CH2 | 1.75 m; 1.63 m | 9; - | 25; 25 |
| 11 | 80.6, C | - | ||
| 12 | 43.9, CH2 | 2.10 brd (13.3); 1.26 brdd (13.3, 9.7) | 13; - | 13, 14; 13, 14 |
| 13 | 53.7, CH | 2.89 brd (9.7) | 12, 14 | 12 |
| 14 | 61.5, CH | 2.66 brd (8.1) | 13, 15 | 15 |
| 15 | 76.0, CH | 2.96 brd (8.1) | 14 | 14, 16, 26 |
| 16 | 36.0, CH | 1.99 m | 26 | |
| 17 | 33.3, CH2 | 1.98 m; 1.37 brt (12.5) | 18; - | 4; - |
| 18 | 38.7, CH | 3.06 brd (12.6) | 17 | |
| 19 | 129.4, CH | 5.70 brs | 4, 18, 21, 23 | |
| 20 | 134.8, C | - | ||
| 21 | 20.7, CH2 | 2.24 m (2H) | 22 | |
| 22 | 35.6, CH2 | 2.07 m; 1.90 m | 21; - | 5; - |
| 23 | 138.3, CH | 6.42 dd (17.4, 10.9) | 24 | 19, 21 |
| 24 | 112.1, CH2 | 5.13 d (17.4); 5.02 d (10.9) | 23; 23 | 20; 20 |
| 25 | 23.7, CH3 | 1.19 s | 10, 11, 12 | |
| 26 | 10.5, CH3 | 1.05 brd (5.3) | 16 | 15, 16, 17 |
| 27 | 17.7, CH3 | 0.96 d (6.6) | 3 | 2, 3, 4 |
Figure 3Partial structures a–d and NMR connectivity of kabirimine (2).
Figure 4Structures of model molecules A–D.
Figure 5Comparison between calculated and experimental optical rotation values of kabirimine (2).